Zobrazeno 1 - 10
of 17
pro vyhledávání: '"María Luisa Martín-Mariscal"'
Autor:
Luis Nieto-Roca, Rocío Carda Barrio, Marta Tomás-Mallebrera, José Antonio Esteban-Chapel, María Luisa Martín-Mariscal
Publikováno v:
REC: Interventional Cardiology, Vol 5, Iss 2, Pp 160-161 (2023)
Se presenta el caso de un varón de 75 años a quien se realiza una coronariografía por disnea de nueva aparición y bloqueo de rama izquierda con lesión larga, difusa y fuertemente calcificada y estenosis máxima del 90% en coronaria derecha domin
Externí odkaz:
https://doaj.org/article/3be1fbbcd63543f59252df3321872500
Autor:
Luis Nieto-Roca, Rocío Carda Barrio, Marta Tomás-Mallebrera, José Antonio Esteban-Chapel, María Luisa Martín-Mariscal
Publikováno v:
REC: Interventional Cardiology (English Ed.), Vol 5, Iss 2, Pp 160-161 (2023)
This is the case of a 75-year-old man who underwent coronary angiography due to new-onset dyspnea and left bundle branch block with a long, diffuse, and heavily calcified lesion with a maximum stenosis of 90% in his dominant right coronary artery. Pa
Externí odkaz:
https://doaj.org/article/a206b92ed15a42a4871c5db3a945bd85
Autor:
Ana María Pello Lázaro, Carmen Cristóbal, Juan Antonio Franco-Peláez, Nieves Tarín, Álvaro Aceña, Rocío Carda, Ana Huelmos, María Luisa Martín-Mariscal, Jesús Fuentes-Antras, Juan Martínez-Millá, Joaquín Alonso, Óscar Lorenzo, Jesús Egido, Lorenzo López-Bescós, José Tuñón
Publikováno v:
PLoS ONE, Vol 12, Iss 1, p e0169826 (2017)
Proton-pump inhibitors (PPIs) seem to increase the incidence of cardiovascular events in patients with coronary artery disease (CAD), mainly in those using clopidogrel. We analysed the impact of PPIs on the prognosis of patients with stable CAD.We fo
Externí odkaz:
https://doaj.org/article/029ab48ee7fa4256907559f235b569f2
Autor:
Roberto Martín-Reyes, Juan Antonio Franco-Peláez, Óscar Lorenzo, María Luisa González-Casaus, Ana María Pello, Álvaro Aceña, Rocío Carda, José Luis Martín-Ventura, Luis Blanco-Colio, María Luisa Martín-Mariscal, Juan Martínez-Milla, Ricardo Villa-Bellosta, Antonio Piñero, Felipe Navarro, Jesús Egido, José Tuñón
Publikováno v:
PLoS ONE, Vol 11, Iss 5, p e0152816 (2016)
BACKGROUND AND OBJECTIVES:We investigated the relationship of the Syntax Score (SS) and coronary artery calcification (CAC), with plasma levels of biomarkers related to cardiovascular damage and mineral metabolism, as there is sparse information in t
Externí odkaz:
https://doaj.org/article/994df5bac7854fbc9b71e7985bdf2c68
Autor:
Juan, Martínez-Milla, Marcelino Cortés, García, Julia Anna, Palfy, Mikel Taibo, Urquía, Marta López, Castillo, Ana Devesa, Arbiol, Ana Lucía Rivero, Monteagudo, María Luisa Martín, Mariscal, Inés, Jiménez-Varas, Sem Briongos, Figuero, Juan Antonio, Franco-Pelaéz, José, Tuñón
Publikováno v:
Journal of Geriatric Cardiology : JGC
OBJECTIVE To assess the role of beta-blockers (BB) in patients with chronic kidney disease (CKD) aged ≥ 75 years. METHODS AND RESULTS From January 2008 to July 2014, we included 390 consecutive patients ≥ 75 years of age with ejection fraction
Autor:
J Tunon, Juan Antonio Franco-Peláez, V Viegas, Rocío Carda, A.M Pello-Lazaro, Álvaro Aceña, M Lopez Castillo, B Merchan-Munoz, Sem Briongos-Figuero, María Luisa Martín-Mariscal
Publikováno v:
European Heart Journal. 41
Background The electrocardiogram (ECG) is an important tool for managing patients with suspected acute myocardial infarction (MI). As it is simple, cost-effective, and fast to use, great effort has been made to study its components for possible use i
Autor:
Marcelino Cortés, J Tunon, M Taibo, A L Rivero-Monteagudo, Marta López-Castillo, S Briongos, J Martinez Milla, Juan Antonio Franco-Peláez, María Luisa Martín-Mariscal, A Devesa-Arbiol
Publikováno v:
European Heart Journal. 41
Introduction Beta-blockers (BB) have been shown to reduce mortality in patients with HFrEF. However, there is little data on the benefit of these therapies in patients with chronic kidney disease and even less in older patients. The aim of this work
Autor:
María Luisa Martín-Mariscal, Juan Antonio Franco-Peláez, Roberto Martín-Reyes, Jesús Egido, José Tuñón, Álvaro Aceña, Luis Miguel Blanco-Colio, María Luisa González-Casaus, Óscar Lorenzo, Ana María Pello-Lázaro, José Luis Martín-Ventura, Rocío Carda, Ignacio Hernández-González
Publikováno v:
Journal of Clinical Medicine
Biblos-e Archivo: Repositorio Institucional de la UAM
Universidad Autónoma de Madrid
Journal of Clinical Medicine, Vol 9, Iss 3037, p 3037 (2020)
Biblos-e Archivo. Repositorio Institucional de la UAM
Consejo Superior de Investigaciones Científicas (CSIC)
Volume 9
Issue 9
Biblos-e Archivo: Repositorio Institucional de la UAM
Universidad Autónoma de Madrid
Journal of Clinical Medicine, Vol 9, Iss 3037, p 3037 (2020)
Biblos-e Archivo. Repositorio Institucional de la UAM
Consejo Superior de Investigaciones Científicas (CSIC)
Volume 9
Issue 9
Our purpose was to assess a possible association of inflammatory, lipid and mineral metabolism biomarkers with coronary artery ectasia (CAE) and to determine a possible association of this with acute atherotrombotic events (AAT). We studied 270 patie
Autor:
María Luisa Martín-Mariscal, Rocío Carda, Juan Antonio Franco-Peláez, Sem Briongos-Figuero, Marta López-Castillo, Beatriz Merchán Muñoz, Ana María Pello-Lázaro, Vanessa Viegas, Álvaro Aceña, José Tuñón
Publikováno v:
Annals of Noninvasive Electrocardiology
Background The presence of pathologic Q waves on admission electrocardiogram (ECG) in patients with anterior ST‐elevated myocardial infarction (STEMI) has been related to adverse cardiac outcomes. Our study evaluates the prognostic value of QRS com
Autor:
José Tuñón, Oscar Lorenzo, María Luisa González-Casaus, Juan Martínez-Milla, María Luisa Martín-Mariscal, Ignacio Hernandez, Marta Lopez Castillo, Juan Antonio Franco Pelaez, Jesús Egido, Ana María Pello Lázaro, Álvaro Aceña, Óscar Lorenzo, Emilio González Parra, Andrea Kallmeyer
Publikováno v:
Journal of cardiovascular translational research. 14(2)
It is essential to study the factors associated with the evolution of aortic stenosis progression (ASP) to develop therapies that could reduce it. We studied 283 patients 6 months after acute coronary syndrome (ACS). ASP was defined as an increase in